We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diagnostic Labs Could Be Overwhelmed with Swine Flu Tests

By LabMedica International staff writers
Posted on 07 Oct 2009
A sudden increase in the number of swine flu cases in the United States could cause problems in diagnostic labs, which are already suffering from a shortage of workers. More...


Laboratory professionals affiliated with the American Society for Clinical Pathology have expressed concern that a large spike in swine flu screenings could slow down testing for other diseases, potentially putting some patients at risk.

There are several tests for H1N1, the virus that causes swine flu, ranging from rapid influenza diagnostic tests, which can detect influenza viral nucleoprotein antigen in as little as 30 minutes, to more sophisticated polymerase chain reaction (PCR) assays. All require lab personnel to administer and review results.

According to Dr. Michael Laposata, chief of pathology at Vanderbilt University Hospital (Nashville, TN, USA), a staff of roughly 300 lab technologists and other workers already has been processing an average of 150 to 200 flu tests--for both swine and regular flu--a day, most of them from the hospital's pediatric emergency room. If there is a significant surge in H1N1 swine flu tests, overtime budgets could be stretched at many hospitals, especially small ones.

At New York University Langone Medical Center (Bronx, NY, USA) lab workers handled an increase of as many as 300 swine flu tests a week during the initial epidemic in the spring and early summer, according to Irina Lutinger, the medical center's senior administrative director of clinical laboratories. If swine flu becomes a full-fledged epidemic this fall and winter, her staff of 45 in the lab's microbiology department could be forced to handle thousands of H1N1 tests per week, she said.

A number of hospitals are coping with the potential surge in swine flu tests by drafting contingency plans. For example, during a serious outbreak, all medical tests would be reviewed and prioritized, and excess tests would be sent to outside labs for analysis. There is also a growing trend among medical professionals and local health departments to recommend H1N1 flu tests only for the sickest patients or for particular surveillance studies.

Emergency room staffers at Montefiore Medical Center (New York, NY, USA) for example, generally reserve swine flu testing for patients who clearly need hospitalization or have serious underlying health problems. Patients who are younger and otherwise healthy are treated and then encouraged to stay home, said Michael Levi, director of clinical microbiology services at the hospital.

Much of the concern among lab directors is due to the fact that since at least the 1990s, fewer people are choosing lab work as a career. Even if they do, fewer training programs are around to serve students, experts say. The American Society for Clinical Pathology said that according to federal statistics, 138,000 new laboratory professionals will be needed nationwide by 2012, but fewer than 50,000 will be trained.

Related Links:

Vanderbilt University Hospital
New York University Langone Medical Center
Montefiore Medical Center



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.